CoChat

Maintenance Treatment for Patients With Bipolar I Disorder: Results From a North American Study of Quetiapine in Combination With Lithium or Divalproex (Trial 127)

Suppes, Trisha, Vieta, Eduard, Liu, Sherry, Brecher, Martin, Paulsson, Björn, Trial 127 Investigators · 2009 · American Journal of Psychiatry

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

OBJECTIVE: The authors evaluated the efficacy and safety of quetiapine plus lithium or divalproex in the prevention of recurrent mood events in patients with stabilized bipolar I disorder. METHOD: A total of 1,953 patients received open-label quetiapine (400-800 mg/day in flexible, divided doses) with either lithium or divalproex (target serum concentrations 0.5-1.2 meq/liter and 50-125 microg/ml, respectively) for up to 36 weeks. After at least 12 weeks of clinical stability, 628 patients were randomly assigned to double-blind treatment with quetiapine or placebo, in combination with lithium or divalproex, for up to 104 weeks. The primary efficacy measure was time to recurrence of any mood event (mania, depression, or a mixed episode). RESULTS: Fewer patients in the quetiapine group experienced a mood event compared with the placebo group (20.3% versus 52.1%). The hazard ratio for time to recurrence of a mood event was 0.32. Hazard ratios were similar for mania and depression events (0.30 and 0.33, respectively). Sedation, weight increase, and hypothyroidism occurred more frequently in the quetiapine group, as did discontinuations due to adverse events. The incidence and incidence density of a single emergent blood glucose value > or =126 mg/dl were higher in the quetiapine group (12.6% versus 5.4%; 18.44 versus 9.56 patients per 100 patient-years). Adverse events were generally consistent with the known tolerability profile of quetiapine. CONCLUSIONS: In patients stabilized on quetiapine plus lithium or divalproex, continued treatment was associated with a significant risk reduction in the time to recurrence of any mood event compared with placebo and lithium or divalproex.

Overview

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2008.08020189

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 38 · Cited by 230

Metadata

Authors
Suppes, T., Vieta, E., Liu, S., Brecher, M., Paulsson, B., & Trial 127 Investigators
Venue
American Journal of Psychiatry
Published
2009-04
Volume
166
Issue
4
Pages
476-488
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2128264233
Cited by
230
References
38
Citations by year
2026: 2 · 2025: 4 · 2024: 9 · 2023: 5 · 2022: 1 · 2021: 7 · 2020: 1 · 2019: 7 · 2018: 6 · 2017: 14 · 2016: 15 · 2015: 18 · 2014: 15 · 2013: 32 · 2012: 30
FWCI
18.63
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
bipolar I disorder, quetiapine, lithium, divalproex, maintenance therapy, mania, depression, hypoglycemia, sedation, weight gain, hypothyroidism, antipsychotic polypharmacy
MeSH terms
Quetiapine Fumarate, Adult, Affect, Bipolar Disorder, Dibenzothiazepines, Dose-Response Relationship, Drug, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Long-Term Care, Male, Middle Aged, Psychiatric Status Rating Scales, Valproic Acid, Lithium Carbonate, Treatment Outcome, Antimanic Agents, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Maintenance Treatment for Patients With Bipolar I Disorder: Results From a North American Study of Quetiapine in Combination With Lithium or Divalproex (Trial 127). https://app.cochat.ai/papers/10.1176/appi.ajp.2008.08020189
The paper
Suppes, T., Vieta, E., Liu, S., Brecher, M., Paulsson, B., & Trial 127 Investigators. (2009). Maintenance Treatment for Patients With Bipolar I Disorder: Results From a North American Study of Quetiapine in Combination With Lithium or Divalproex (Trial 127). American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2008.08020189

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.